Geode Capital Management’s Acorda Therapeutics ACOR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
|
|||||
2023
Q1 | $39.1K | Sell |
|
|||||
2022
Q4 | $51K | Buy |
|
|||||
2022
Q3 | $13K | Hold |
|
|||||
2022
Q2 | $21K | Hold |
|
|||||
2022
Q1 | $75K | Hold |
|
|||||
2021
Q4 | $111K | Hold |
|
|||||
2021
Q3 | $214K | Sell |
|
|||||
2021
Q2 | $350K | Buy |
|
|||||
2021
Q1 | $315K | Sell |
|
|||||
2020
Q4 | $283K | Buy |
|
|||||
2020
Q3 | $186K | Sell |
|
|||||
2020
Q2 | $268K | Sell |
|
|||||
2020
Q1 | $603K | Sell |
|
|||||
2019
Q4 | $1.41M | Buy |
|
|||||
2019
Q3 | $1.62M | Sell |
|
|||||
2019
Q2 | $4.89M | Buy |
|
|||||
2019
Q1 | $7.61M | Buy |
|
|||||
2018
Q4 | $8.4M | Sell |
|
|||||
2018
Q3 | $10.8M | Buy |
|
|||||
2018
Q2 | $14.4M | Buy |
|
|||||
2018
Q1 | $9.91M | Buy |
|
|||||
2017
Q4 | $8.79M | Sell |
|
|||||
2017
Q3 | $10.2M | Sell |
|
|||||
2017
Q2 | $8.95M | Buy |
|
|||||
2017
Q1 | $9.26M | Buy |
|
|||||
2016
Q4 | $7.67M | Buy |
|
|||||
2016
Q3 | $8M | Buy |
|
|||||
2016
Q2 | $9.24M | Buy |
|
|||||
2016
Q1 | $9.41K | Buy |
|
|||||
2015
Q4 | $13.5M | Buy |
|
|||||
2015
Q3 | $7.81M | Buy |
|
|||||
2015
Q2 | $9.72M | Buy |
|
|||||
2015
Q1 | $8.89M | Sell |
|
|||||
2014
Q4 | $11.6M | Buy |
|
|||||
2014
Q3 | $9.46M | Buy |
|
|||||
2014
Q2 | $8.73M | Buy |
|
|||||
2014
Q1 | $8.36M | Buy |
|
|||||
2013
Q4 | $6.02M | Buy |
|
|||||
2013
Q3 | $6.37M | Buy |
|
|||||
2013
Q2 | $5.73M | Buy |
|